Publications by the researcher in collaboration with ALICIA RODRÍGUEZ GASCÓN (12)
2024
-
Gene therapy with lipid nanoparticles for Fabry disease: Leveraging E-selectin for targeted delivery to endothelial cells
Journal of Drug Delivery Science and Technology, Vol. 99
-
Systematic Review of Genetic Substrate Reduction Therapy in Lysosomal Storage Diseases: Opportunities, Challenges and Delivery Systems
BioDrugs, Vol. 38, Núm. 5, pp. 657-680
-
Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review
Drug Delivery and Translational Research, Vol. 14, Núm. 10, pp. 2615-2628
2023
-
Expression of a conserved sequence of SARS-CoV-2 for panβ-coronavirus vaccine development
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
-
Nanopartículas lipídicas funcionalizadas con GalNAc para suplementación génica: aplicación en la enfermedad de Fabry
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
-
Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease
Pharmaceutics, Vol. 15, Núm. 7
-
siRNA vectors based on golden lipid nanoparticles for Fabry Disease
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
2022
-
Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease
Nanomaterials, Vol. 12, Núm. 14
-
mRNA delivery technologies: Toward clinical translation
International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 207-293
2021
-
Functionalised SLNs-based nanovectors for gene therapy in Fabry disease: The liver as an α-Galactosidase A factory
RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 46-48
-
Mrna-based nanomedicinal products to address corneal inflammation by interleukin-10 supplementation
Pharmaceutics, Vol. 13, Núm. 9
-
Substrate reduction therapy based on siRNA for Fabry Disease
RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 84-86